Legend Star

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 152
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 123
Rounds per year 10.86
Lead investments 19
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 4
Key employees 3
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Software
  • Artificial Intelligence
Summary

Legend Star appeared to be the VC, which was created in 2008. The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.

The top amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Legend Star works on 27 percentage points less the average amount of lead investments. The fund is constantly included in 7-12 investment rounds annually. When the investment is from Legend Star the average startup value is 50-100 millions dollars. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity.

Among the most popular portfolio startups of the fund, we may highlight Pony.ai, Burning Rock Biotech, Orvibo. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Mobile, Information Technology. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.

We also calculated 3 valuable employees in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Legend Star, startups are often financed by ZhenFund, Comet Labs, The Cross Country Group. The meaningful sponsors for the fund in investment in the same round are Legend Capital, Sequoia Capital China, LYFE Capital. In the next rounds fund is usually obtained by Sequoia Capital China, Legend Capital, Baidu Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Legend Star:
Typical Co-investors
Legend Star is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Legend Star:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

J-Elephant

Industrial Automation
Manufacturing
Robotics
27 Apr 2022 Beijing, Beijing, China

Aiden Technology

Analytics
Artificial Intelligence
Big Data
Consulting
$30M31 Mar 2022 Beijing, Beijing, China

Tensor Security

16 Mar 2022 Beijing, Beijing, China

Blue Elephant Zhilian

Financial Services
Service Industry
Software
$30M09 Feb 2022 Hangzhou, Zhejiang, China

Axera

Artificial Intelligence
Computer Vision
$123M17 Jan 2022 Haidian District, Beijing, China

Axera

Artificial Intelligence
Computer Vision
31 Dec 2021 Haidian District, Beijing, China

IBT Wujiang Technology

Health Care
Medical
Medical Device
28 Dec 2021 Beijing, Beijing, China

Cargene

Biopharma
Biotechnology
Therapeutics
$19M14 Dec 2021 Singapore, Central Region, Singapore

Carcell Biopharma

Biotechnology
Genetics
Medical
$15M01 Nov 2021 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Legend Star?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: